middle.news
InhaleRx Accelerates Inhaled Drug Trials with $38.5M Funding and Ethics Green Light
11:52am on Tuesday 22nd of July, 2025 AEST
•
Healthcare
Read Story
InhaleRx Accelerates Inhaled Drug Trials with $38.5M Funding and Ethics Green Light
11:52am on Tuesday 22nd of July, 2025 AEST
Key Points
Ethics approval granted swiftly for IRX-211 Phase 2 trial resubmission
Manufacturing commenced for IRX-211 trial drugs and planning underway for IRX-616a Phase 1 trial
First $248k drawdown from $38.5m Clendon funding facility executed
Received $489k in Australian Government R&D incentives during the quarter
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IRX
OPEN ARTICLE